Table 1 Summary of RIG samples included in the study.

From: Comprehensive molecular characterization of pediatric radiation-induced high-grade glioma

 

First cancer

Rad dose/field

    

RNA

DNA

ID

Age

His

Dose (Gy)

Field

Lat (y)

Status

Clin

RIG

Seq

Seq

Meth

1

ALL

No

HGG

WES

EPIC

2

14.3

G,O

59.4

Focal

9

D

Yes

GBM

WES

EPIC

2B

G,O

Yes

EPIC

5

3.6

C

54

Focal

12

D

No

GBM

WES

EPIC

6

7.1

M

6

D

No

HGG

EPIC

7

M

No

HGG

WES

8

Ge

No

HGG

WES

EPIC

9

M

Yes

HGG

WES

EPIC

11

0.16

G,O

Focal

13

D

Yes

HGG

EPIC

12

3.5

ALL

24

CR

13

D

Yes

GBM

WGS

EPIC

12B

ALL

Yes

450 K

13

0.3

G,O

49.5

Focal

3

D

Yes

HGG

EPIC

14

1.5

ALL

18

CSI

8

D

Yes

GBM

EPIC

14B

ALL

Yes

EPIC

15

12.4

Ge

51

Focal

7

D

Yes

HGG

EPIC

16

5.8

M

X, 55.8

CSI

7

D

Yes

GBM

EPIC

18

10.2

M

23.4, 55.8

Focal

8

D

Yes

AA

EPIC

19

8

M

X, 55.8

Focal

3

D

Yes

HGG

EPIC

20

15

Ga

Focal

4

Yes

GBM

EPIC

21

7

BL

CSI

7

D

Yes

GBM

A

WGS

EPIC

22

ALL

TBI

D

Yes

GBM

B

EPIC

23

8

M

24, 54–55.8

CSI

4

D

Yes

GBM

B

WGS

EPIC

24

10

M

23.4, 54

CSI

13

D

Yes

GBM

B

WGS

EPIC

25

11

E

54

Focal

12

D

Yes

GBM

A

EPIC

26

3

ALL

CR

13

D

Yes

GBM

A

EPIC

27

4

M

23.4, 54

CSI

7

D

Yes

HGG

A

WGS

EPIC

28

19

M

36, 54

CSI

7

D

Yes

GBM

B

WGS

EPIC

29

3

ALL

21

CR

4

D

Yes

GBM

B

WGS

EPIC

30

2

ALL

18

CR

10

D

Yes

GBM

A

WGS

EPIC

31

4

M

X, 54–55.8

CSI

7

D

Yes

GBM

B

WGS

EPIC

32

9

ALL

12

TBI

D

Yes

AA

A

WGS

EPIC

33

7

M

23.4, 54

CSI

10

D

No

GBM

B

WGS

EPIC

34

6

ALL

TBI

8

D

Yes

AA

WGS

450 K

42

8.8

E

23

No

HGG

EPIC

43

2.3

ALL

11

D

No

HGG

EPIC

  1. Histology (His): ALL acute lymphoblastic leukemia, BL Burkitt lymphoma, C craniopharyngioma, E ependymoma, Ga ganglioglioma, Ge germinoma, G,O glial, other, M medulloblastoma.
  2. Clin: Clinical history reviewed (Yes/No); RIG: AA anaplastic astrocytoma, GBM glioblastoma, HGG high-grade glioma.
  3. RNA-Seq: A Subgroup A tumor with RNA-Seq data, B Subgroup B tumor with RNA-Seq data.